Shares of Evotec SE (ETR:EVT – Get Free Report) traded up 0.3% on Tuesday . The stock traded as high as €10.50 ($11.05) and last traded at €10.50 ($11.05). 2,505,337 shares changed hands during mid-day trading, an increase of 84% from the average session volume of 1,360,000 shares. The stock had previously closed at €10.47 ($11.02).
Evotec Stock Up 3.0 %
The company has a current ratio of 1.83, a quick ratio of 2.97 and a debt-to-equity ratio of 46.81. The company has a 50 day simple moving average of €6.77 and a two-hundred day simple moving average of €7.73. The firm has a market capitalization of $1.76 billion, a P/E ratio of -10.32, a P/E/G ratio of 0.98 and a beta of 1.05.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Recommended Stories
- Five stocks we like better than Evotec
- What is Put Option Volume?
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Using the MarketBeat Dividend Yield Calculator
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Breakout Stocks: What They Are and How to Identify Them
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
